About this course

Learning Objectives

• Identify the challenges associated with traditional assessment methods of negative symptoms.
• Describe emerging digital technologies employed in the assessment of negative symptoms.
• Explain future areas of research and clinical use of exercise in negative symptoms.

Learning Levels

• Beginner
• Intermediate
• Advanced

Course Instructor(s)

• David Kimhy, PhD

  Associate Professor, Icahn School of Medicine at Mount Sinai

  Dr. David Kimhy is a clinical psychologist and a digital mental health entrepreneur with expertise in the development of cognitive and behavioral treatments for serious mental illness. He has more than 20 years' experience designing and leading randomized clinical trials focusing on the use of cognitive and behavioral interventions and technology-based approaches in the assessment and treatment of serious mental illness. This work resulted in more than 90 peer-reviewed research articles, book chapters, and books.

  Most recently Dr. Kimhy served as an Associate Professor (tenured) at the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai, the Director of the Experimental Psychopathology Laboratory, and the Program Leader for New Interventions in Schizophrenia. He pioneered the use of digital mobile health technologies in the study of psychosis, having published the first studies validating the use of digital phenotyping of patients with schizophrenia and its integration with wearable sensor technologies. His research has been funded by grants from the National Institute of Mental Health, the VA Administration, as well as private and institutional funding.

  Dr. Kimhy is the founder and principal of Vital Psychological Therapeutics, the first national telehealth-based psychotherapy practice dedicated to the treatment of individuals with psychosis.

Disclosure

References

• Kurtzman, G., Badawi, J. C., Boyd, C. E., Kimhy, D., Torous, J., & Patriquin, M. A. (2025). Digital Interventions in Inpatient Psychiatry. Journal of Psychiatric Practice®, 31(5), 238-244. https://doi.org/10.1097/PRA.0000000000000882
• Strauss, G. P., Raugh, I. M., Zhang, L., Luther, L., Chapman, H. C., Allen, D. N., ... & Cohen, A. S. (2022). Validation of accelerometry as a digital phenotyping measure of negative symptoms in schizophrenia. Schizophrenia, 8(1), 37. https://doi.org/10.1038/s41537-022-00241-z
• Kimhy, D., Tay, C., Vakhrusheva, J., Beck-Felts, K., Ospina, L. H., Ifrah, C., ... & Bartels, M. N. (2021). Enhancement of aerobic fitness improves social functioning in individuals with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 271(2), 367-376. https://doi.org/10.1007/s00406-020-01220-0
• Cohen, A. S., Schwartz, E., Le, T. P., Cowan, T., Kirkpatrick, B., Raugh, I. M., & Strauss, G. P. (2021). Digital phenotyping of negative symptoms: the relationship to clinician ratings. Schizophrenia Bulletin, 47(1), 44-53. https://doi.org/10.1093/schbul/sbaa065
• Kimhy, D., Myin-Germeys, I., Palmier-Claus, J., & Swendsen, J. (2012). Mobile assessment guide for research in schizophrenia and severe mental disorders. Schizophrenia bulletin, 38(3), 386-395. https://doi.org/10.1093/schbul/sbr186
• Kimhy, D., Delespaul, P., Ahn, H., Cai, S., Shikhman, M., Lieberman, J. A., ... & Sloan, R. P. (2010). Concurrent measurement of “real-world” stress and arousal in individuals with psychosis: assessing the feasibility and validity of a novel methodology. Schizophrenia bulletin, 36(6), 1131-1139. https://doi.org/10.1093/schbul/sbp028
• Kimhy, D., Delespaul, P., Corcoran, C., Ahn, H., Yale, S., & Malaspina, D. (2006). Computerized experience sampling method (ESMc): assessing feasibility and validity among individuals with schizophrenia. Journal of psychiatric research, 40(3), 221-230. https://doi.org/10.1016/j.jpsychires.2005.09.007